[COVID 19 infection: age-stratified population-based cohort seroepidemiological study in Asunción and Central].

Pub Date : 2022-06-01 DOI:10.4067/s0716-10182022000200238
Águeda Cabello, Margarita Samudio, Guillermo Sequera, Sandra Ocampos, Rosa Galeano, Cynthia Vázquez
{"title":"[COVID 19 infection: age-stratified population-based cohort seroepidemiological study in Asunción and Central].","authors":"Águeda Cabello,&nbsp;Margarita Samudio,&nbsp;Guillermo Sequera,&nbsp;Sandra Ocampos,&nbsp;Rosa Galeano,&nbsp;Cynthia Vázquez","doi":"10.4067/s0716-10182022000200238","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>COVID-19, caused by the severe acute respiratory syndrome virus type-2 (SARS-CoV-2), was declared a pandemic in March 2020. Seroprevalence studies are useful to estimate the proportion of the population previously infected, quantify the magnitude of transmission, estimate the fatality rate, evaluate the effect of interventions, and estimate the degree of immunity of the population.</p><p><strong>Aim: </strong>To determine the extension of the infection and the cumulative incidence of age-specific infection, determined by seropositivity in the population of the sanitary regions of Asunción and the Central Department of Paraguay.</p><p><strong>Methods: </strong>Population-based cohort study. In Asunción 126 households and in the Central Department 609 were surveyed between December 2020 to March 2021. Three visits were made to the selected households.</p><p><strong>Results: </strong>The testing rate was 66.6%, 1,699 people (324 in Asunción and 1,375 in Central) of the 2,553 people registered. In the first, second and third rounds, seroprevalences were 15.5%, 15.4% and 14.3% in Asunción, respectively; in Central 23.1%, 27.8% and 26.9%, respectively. There was a seroconversion between the first and second rounds of 5.9%, and in the third round 6.5%; the accumulated global seroprevalence was 26.9% (95% CI: 24.8-19.1); in Asunción 23.1% (95% CI: 18.9-28.0) and in Central 27.8% (95% CI: 25.5-30.2). 8.5% of the participants reported symptoms; of them, 54.2% had positive serology.</p><p><strong>Conclusion: </strong>The sero-prevalence was high with a low proportion of people with symptoms.</p>","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4067/s0716-10182022000200238","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Background: COVID-19, caused by the severe acute respiratory syndrome virus type-2 (SARS-CoV-2), was declared a pandemic in March 2020. Seroprevalence studies are useful to estimate the proportion of the population previously infected, quantify the magnitude of transmission, estimate the fatality rate, evaluate the effect of interventions, and estimate the degree of immunity of the population.

Aim: To determine the extension of the infection and the cumulative incidence of age-specific infection, determined by seropositivity in the population of the sanitary regions of Asunción and the Central Department of Paraguay.

Methods: Population-based cohort study. In Asunción 126 households and in the Central Department 609 were surveyed between December 2020 to March 2021. Three visits were made to the selected households.

Results: The testing rate was 66.6%, 1,699 people (324 in Asunción and 1,375 in Central) of the 2,553 people registered. In the first, second and third rounds, seroprevalences were 15.5%, 15.4% and 14.3% in Asunción, respectively; in Central 23.1%, 27.8% and 26.9%, respectively. There was a seroconversion between the first and second rounds of 5.9%, and in the third round 6.5%; the accumulated global seroprevalence was 26.9% (95% CI: 24.8-19.1); in Asunción 23.1% (95% CI: 18.9-28.0) and in Central 27.8% (95% CI: 25.5-30.2). 8.5% of the participants reported symptoms; of them, 54.2% had positive serology.

Conclusion: The sero-prevalence was high with a low proportion of people with symptoms.

分享
查看原文
[COVID - 19感染:Asunción和Central地区年龄分层人群队列血清流行病学研究]。
背景:由SARS-CoV-2病毒引起的COVID-19于2020年3月被宣布为大流行。血清流行率研究有助于估计以前感染的人口比例,量化传播程度,估计死亡率,评估干预措施的效果,并估计人口的免疫程度。目的:确定感染的延伸和年龄特异性感染的累积发病率,由Asunción卫生区和巴拉圭中央省的人口血清阳性确定。方法:基于人群的队列研究。在2020年12月至2021年3月期间,对Asunción 126个家庭和中央部的609个家庭进行了调查。对选定的家庭进行了三次访问。结果:在登记的2553人中,检测率为66.6%,1699人(Asunción 324人,中环1375人)。在第一轮、第二轮和第三轮,Asunción的血清患病率分别为15.5%、15.4%和14.3%;,分别为23.1%、27.8%及26.9%。第一轮和第二轮血清转化率为5.9%,第三轮为6.5%;全球累计血清阳性率为26.9% (95% CI: 24.8-19.1);Asunción 23.1% (95% CI: 18.9-28.0), Central 27.8% (95% CI: 25.5-30.2)。8.5%的参与者报告了症状;其中血清学阳性54.2%。结论:血清学患病率高,有症状者比例低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信